Skip to main content

Advertisement

ADVERTISEMENT

Supplements

The objective of this study was to determine the ability of two NPWT systems—System A (Invia Liberty; Medela AG) and System B (RENASYS TOUCH; Smith+Nephew)—to deliver a set level of negative pressure when the device was positioned at different heights in relation to the wound bed and during a simulated fluid bolus. This supplement was not subject to the Wounds peer-review process. ...
In this supplement, articles from the 2021 Mechanically Powered Negative Pressure Wound Therapy (mNPWT) Case Compendium Contest with Wounds are presented. 
An international, multispecialty advisory panel participated in individual virtual interviews during January and February 2021 to assess single-use NPWT (sNPWT) as part of a care bundle that potentially could maximize clinical and financial efficacy. This supplement was subject to the WOUNDS peer-review process.
The objective of this study was to determine the ability of 2 negative pressure wound therapy systems to deliver a set level of negative pressure when the device is at different heights and also during a simulated fluid bolus. This supplement was not subject to the WOUNDS peer-review process.
This sponsored paper addresses the topic of placental-derived allografts in the treatment of hard-to-heal wounds; it was sponsored by MIMEDX and was not subject to the WOUNDS peer-review process.
This supplemental offers a brief introduction, commentary piece, and instructional video on the product ActiGraft. This was supported by SeaGlassMedical and was not subject to the Wounds peer-review process.
In this presentation slide deck from SAWC Spring 2021, Jason Anderson, DPM, FACFAS, and Alison J. Garten, DPM, CPED, discuss and highlight cases in which placental tissues were used to achieve wound closure.

Advertisement